ADMA

NASDAQ HEALTHCARE

ADMA Biologics Inc

$11.07

$0.38 (+3.60%)

Live quote

52w: $7.21 – $20.46

Loading chart…

P/E Ratio16.28

P/B Ratio5.86

EV/EBITDA—

Debt/Equity—

ROE35.99%

ROIC—

Revenue Growth19.63%

Gross Margin57.39%

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.

Own ADMA? Track it here.

Create a free account to add ADMA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account